[18F] F-GLN PET/CT Imaging for Breast Cancer
[18F] F-GLN by PET/CT in Breast Cancer
Recruiting
Phase 1
Interventional Study
Breast Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 40 (estimated)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Other
Who this trial is looking for
This trial is looking for adults with breast cancer to participate in a study using a special imaging technique. Participants will get an injection and have scans to gather information about breast cancer.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 18 years old.
- I have been diagnosed with breast cancer.
- I have at least one lesion that is 1.0 cm or larger seen on imaging.
- I am willing to provide written consent to participate.
You may not be able to join if
- I am pregnant or breastfeeding.
- I cannot tolerate imaging procedures.
- I have a medical condition that could affect my safety in the study.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Patients with known or suspected primary or metastatic breast cancer with one lesion that is 1.0 cm in diameter or greater may be eligible for this study. Patients may participate in this study if they are at least 18 years of age. Up to 40 evaluable subjects will participate in a single imaging cohort. Patients will be stratified for analysis by breast cancer subtype with prioritization to recrui…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participants will be ≥ 18 years of age
* Known or suspected primary or metastatic breast cancer.
* At least one lesion ≥ 1.0 cm that is seen on standard imaging (e.g. CT, MRI, mammogram, ultrasound, FDG-PET/CT). Only one type of imaging is required to show a lesion.
* Particip…
Contacts